CA2325848A1 - Proteine liee au facteur de croissance des lymphocytes b - Google Patents

Proteine liee au facteur de croissance des lymphocytes b Download PDF

Info

Publication number
CA2325848A1
CA2325848A1 CA002325848A CA2325848A CA2325848A1 CA 2325848 A1 CA2325848 A1 CA 2325848A1 CA 002325848 A CA002325848 A CA 002325848A CA 2325848 A CA2325848 A CA 2325848A CA 2325848 A1 CA2325848 A1 CA 2325848A1
Authority
CA
Canada
Prior art keywords
bgfrp
polynucleotide
sequence
polypeptide
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002325848A
Other languages
English (en)
Inventor
Y. Tom Tang
Neil C. Corley
Mariah Baughn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2325848A1 publication Critical patent/CA2325848A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne une protéine liée au facteur de croissance des lymphocytes B humains (BGFRP), et des polynucléotides qui identifient et codent la BGFRP. L'invention se rapporte également à des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne enfin des procédés de diagnostic, de traitement et de prévention d'affections liées à l'expression de la BGFRP.
CA002325848A 1998-04-20 1999-04-06 Proteine liee au facteur de croissance des lymphocytes b Abandoned CA2325848A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6362398A 1998-04-20 1998-04-20
US09/063,623 1998-04-20
PCT/US1999/007592 WO1999054469A1 (fr) 1998-04-20 1999-04-06 Proteine liee au facteur de croissance des lymphocytes b

Publications (1)

Publication Number Publication Date
CA2325848A1 true CA2325848A1 (fr) 1999-10-28

Family

ID=22050434

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002325848A Abandoned CA2325848A1 (fr) 1998-04-20 1999-04-06 Proteine liee au facteur de croissance des lymphocytes b

Country Status (5)

Country Link
EP (1) EP1071781A1 (fr)
JP (1) JP2002512034A (fr)
AU (1) AU3476099A (fr)
CA (1) CA2325848A1 (fr)
WO (1) WO1999054469A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7082487A (en) * 1986-02-11 1987-08-25 University Of Texas System, The Recombinant human b-cell growth factor
WO1997034998A1 (fr) * 1996-03-20 1997-09-25 Human Genome Sciences, Inc. Polypeptides cytokines humains

Also Published As

Publication number Publication date
EP1071781A1 (fr) 2001-01-31
AU3476099A (en) 1999-11-08
JP2002512034A (ja) 2002-04-23
WO1999054469A1 (fr) 1999-10-28

Similar Documents

Publication Publication Date Title
CA2328905A1 (fr) Proteines de membrane associees a la croissance de la prostate
WO1999051640A1 (fr) Recepteur de lipoproteines de faible poids moleculaire (ldl) oxydees de l'etre humain
WO1999058692A2 (fr) Proteines associees a l'apoptose humaine
CA2296447A1 (fr) Proteine humaine de transport de cassette de liaison de l'adenosine triphosphate (atp)
US6391580B1 (en) Ras proteins
US5942399A (en) Amino acid permease homolog
US6077693A (en) Polynucleotide encoding a promonocyte associated protein
US20020106373A1 (en) Proteins associated with EGF signaling
CA2321746A1 (fr) Inhibiteur de proteine-kinase c humaine
WO1999015659A2 (fr) Enzymes de conjugaison de l'ubiquitine humaine
US6277568B1 (en) Nucleic acids encoding human ubiquitin-conjugating enzyme homologs
CA2292643A1 (fr) Proteines liees aux cyclines
US6432687B1 (en) Delayed rectifier potassium channel subunit
US20040086923A1 (en) Carbamoyl phosphate synthase homolog
CA2300918A1 (fr) Enzyme de conjugaison de l'ubiquitine ressemblant a ubc7
WO2000004150A1 (fr) Proteine humaine associee a la preseniline
CA2321870A1 (fr) Proteines liees au cycle cellulaire
CA2294563A1 (fr) Nouvelle lysophospholipase humaine
CA2325848A1 (fr) Proteine liee au facteur de croissance des lymphocytes b
CA2333006A1 (fr) Proteine associee a la calmoduline
US20030109451A1 (en) Human arsenite-resistance protein
CA2288073A1 (fr) Lysophospholipase humaine
WO1999061612A1 (fr) Suppresseur de tumeur
EP1078070A2 (fr) Methylases d'acides nucleiques humains
CA2317920A1 (fr) Proteine humaine de calcineurine de type b

Legal Events

Date Code Title Description
FZDE Dead